T E King

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Clinical advances in the diagnosis and therapy of the interstitial lung diseases
    Talmadge E King
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, CA 94110, USA
    Am J Respir Crit Care Med 172:268-79. 2005
  2. ncbi Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality
    T E King
    Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California 94110, USA
    Am J Respir Crit Care Med 164:1025-32. 2001
  3. ncbi Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model
    T E King
    Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco 94110, USA
    Am J Respir Crit Care Med 164:1171-81. 2001
  4. ncbi Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis
    Talmadge E King
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, San Francisco, CA 94110, USA
    Chest 127:171-7. 2005
  5. ncbi Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management
    Talmadge E King
    Interstitial Lung Disease Center, San Francisco General Hospital, San Francisco, CA 94110, USA
    Trans Am Clin Climatol Assoc 115:43-76; discussion 76-8. 2004
  6. ncbi Demystifying idiopathic interstitial pneumonia
    Harold R Collard
    Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, USA
    Arch Intern Med 163:17-29. 2003
  7. ncbi Acute interstitial pneumonitis. Case series and review of the literature
    J S Vourlekis
    Department of Medicine, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, 1400 Jackson Street, F107, Denver, CO 80206, USA
    Medicine (Baltimore) 79:369-78. 2000
  8. ncbi Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
    J S Lee
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Eur Respir J 39:352-8. 2012
  9. ncbi Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias
    Michael B Gotway
    Department of Radiology, University of California at San Francisco, and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, USA
    Thorax 62:546-53. 2007
  10. ncbi Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern
    Eunice J Kim
    Division of Pulmonary and Critical CareMedicine, Department of Medicine, University of California at San Francisco, CA, USA
    Chest 136:1397-405. 2009

Research Grants

  1. Idiopathic Pulmonary Fibrosis Clinical Research Network
    TALMADGE KING; Fiscal Year: 2007

Detail Information

Publications57

  1. ncbi Clinical advances in the diagnosis and therapy of the interstitial lung diseases
    Talmadge E King
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, CA 94110, USA
    Am J Respir Crit Care Med 172:268-79. 2005
    ..This article highlights some of the advances and changes in clinical practice that took place in the management of patients with interstitial lung diseases over the last century...
  2. ncbi Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality
    T E King
    Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco, San Francisco, California 94110, USA
    Am J Respir Crit Care Med 164:1025-32. 2001
    ..Controlling these processes, rather than stopping inflammation, appears most important in preventing progressive disease and the fatal outcome common in IPF...
  3. ncbi Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model
    T E King
    Department of Medicine, San Francisco General Hospital, and the University of California, San Francisco 94110, USA
    Am J Respir Crit Care Med 164:1171-81. 2001
    ....
  4. ncbi Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis
    Talmadge E King
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, San Francisco, CA 94110, USA
    Chest 127:171-7. 2005
    ..Idiopathic pulmonary fibrosis (IPF) is a devastating disease, yet validated, reliable criteria for evaluating patient response to therapies in clinical trials are lacking...
  5. ncbi Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management
    Talmadge E King
    Interstitial Lung Disease Center, San Francisco General Hospital, San Francisco, CA 94110, USA
    Trans Am Clin Climatol Assoc 115:43-76; discussion 76-8. 2004
    ....
  6. ncbi Demystifying idiopathic interstitial pneumonia
    Harold R Collard
    Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, USA
    Arch Intern Med 163:17-29. 2003
    ....
  7. ncbi Acute interstitial pneumonitis. Case series and review of the literature
    J S Vourlekis
    Department of Medicine, National Jewish Medical and Research Center, University of Colorado Health Sciences Center, 1400 Jackson Street, F107, Denver, CO 80206, USA
    Medicine (Baltimore) 79:369-78. 2000
    ..Likewise, there were no features that predicted the longitudinal course in survivors. Further study to identify causal factors is required in the hope of preventing morbidity and mortality related to this disease...
  8. ncbi Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis
    J S Lee
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Eur Respir J 39:352-8. 2012
    ..Pepsin level was not an independent predictor of survival time. These results suggest occult aspiration may play a role in some cases of acute exacerbation of idiopathic pulmonary fibrosis...
  9. ncbi Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias
    Michael B Gotway
    Department of Radiology, University of California at San Francisco, and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, USA
    Thorax 62:546-53. 2007
    ..The role of surgical lung biopsy is discussed in the diagnosis of cases when a definite HRCT diagnosis cannot be made...
  10. ncbi Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern
    Eunice J Kim
    Division of Pulmonary and Critical CareMedicine, Department of Medicine, University of California at San Francisco, CA, USA
    Chest 136:1397-405. 2009
    ..In patients in whom the underlying pattern cannot be determined by HRCT scanning, surgical lung biopsy should be considered...
  11. ncbi Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
    Kevin R Flaherty
    Division of Pulmonary and Critical Care Medicine, Department of Radiology, University of Michigan Health System, 3916 Taubman Center, 1500 E Medical Center Drive, Ann Arbor, MI 48109 0360, USA
    Am J Respir Crit Care Med 170:904-10. 2004
    ..We conclude that dynamic interactions between clinicians, radiologists, and pathologists improve interobserver agreement and diagnostic confidence...
  12. ncbi Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
    Talmadge E King
    Department of Medicine, University of California San Francisco, San Francisco, CA 94143 0120, USA
    Lancet 374:222-8. 2009
    ..We assessed whether treatment with interferon gamma-1b improved survival compared with placebo in patients with idiopathic pulmonary fibrosis and mild-to-moderate impairment of pulmonary function...
  13. ncbi Bosentan for idiopathic pulmonary fibrosis
    Talmadge E King
    University of California San Francisco, Department of Medicine, San Francisco, CA 94143 0120, USA
    Curr Opin Investig Drugs 9:1171-9. 2008
    ..These observations are being investigated in the ongoing BUILD-3 trial...
  14. ncbi Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians
    Harold R Collard
    Department of Medicine, San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, 5K1, San Francisco, CA 94110, USA
    Respir Med 101:2011-6. 2007
    ..These results suggest there is general consensus regarding the approach to diagnosis, but that there is no consensus about medical management in IPF...
  15. ncbi Current perspectives on the treatment of idiopathic pulmonary fibrosis
    Nicholas Walter
    San Francisco General Hospital, 1001 Potrero Avenue, Room 5H22, San Francisco, CA 94110, USA
    Proc Am Thorac Soc 3:330-8. 2006
    ..g., IFN-gamma1b, pirfenidone, N-acetylcysteine, coumadin, bosentan, or etanercept). This article examines the body of evidence supporting the current therapies and reviews the newer agents being tested in patients with IPF...
  16. ncbi Clinical problem-solving. Anchors away
    Carolyn S Calfee
    Department of Medicine, University of California, San Francisco, USA
    N Engl J Med 356:504-9. 2007
  17. ncbi Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis
    Harold R Collard
    Department of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO, USA
    Chest 125:2169-74. 2004
    ....
  18. ncbi Does chronic microaspiration cause idiopathic pulmonary fibrosis?
    Joyce S Lee
    Department of Medicine, University of California, San Francisco, CA, USA
    Am J Med 123:304-11. 2010
    ..Defining the role of chronic microaspiration in idiopathic pulmonary fibrosis is essential as it has potential clinical, pathobiological, and treatment implications for this deadly disease...
  19. ncbi Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence
    David G Morris
    Interstitial Lung Disease Program, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, CA 94142 0854, USA
    Chest 124:929-35. 2003
    ..The chronic granulomatous inflammation of sarcoidosis has been hypothesized to depend on the CD4+ T-helper lymphocyte. HIV infection, which depletes these cells, has been reported to attenuate the manifestations of sarcoidosis...
  20. ncbi BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
    Talmadge E King
    Department of Medicine, UCSF, 505 Parnassus Avenue, Room M994, San Francisco, CA 94110, USA
    Am J Respir Crit Care Med 177:75-81. 2008
    ..Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease lacking effective treatment...
  21. ncbi Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
    E J Kim
    Dept of Medicine, University of California, San Francisco, CA 94143, USA
    Eur Respir J 35:1322-8. 2010
    ..96) were associated with better survival. A definite usual interstitial pneumonia pattern on HRCT has important prognostic implications in RA-ILD...
  22. ncbi Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
    G Raghu
    Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, Seattle, WA 98195 6522, USA
    Eur Respir J 35:118-23. 2010
    ..Observations from exploratory analyses suggested benefits of bosentan on HRQoL among patients who had undergone surgical lung biopsy for diagnosis, and they merit further investigation...
  23. ncbi Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function
    Brent W Kinder
    Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267 0564, USA
    Lung 188:143-9. 2010
    ..These findings demonstrate the clinical importance of identifying UCTD in patients presenting with an "idiopathic" interstitial pneumonia...
  24. ncbi Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis
    Jason S Vourlekis
    Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, USA
    Am J Med 112:490-3. 2002
  25. ncbi Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders
    Y Inoue
    Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA
    Am J Pathol 149:2037-54. 1996
    ....
  26. ncbi Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis
    G W Hunninghake
    Department of Medicine, University of Iowa and Veterans Affairs Medical Center, Iowa City, IA 52242, USA
    Am J Respir Crit Care Med 164:193-6. 2001
    ..Lung biopsy is most helpful when clinical and radiologic data result in an uncertain diagnosis or when patients are thought not to have IPF...
  27. ncbi A new look at the pathophysiology of asthma
    T E King
    Department of Medicine, San Francisco General Hospital, 1001 Potrero Ave, Room 5H22, San Francisco, CA 94110, USA
    J Natl Med Assoc 91:9S-15S. 1999
    ....
  28. ncbi Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis
    Brent W Kinder
    Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Chest 133:226-32. 2008
    ..We hypothesized that baseline BAL fluid cell count differential (ie, elevated levels of neutrophils and eosinophils, or reduced levels of lymphocytes) would predict higher mortality among persons with IPF...
  29. ncbi Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
    Harold R Collard
    Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Health Sciences Center, 1400 Jackson Street, Room F107, Denver, CO 80206, USA
    Am J Respir Crit Care Med 168:538-42. 2003
    ..Evaluation of changes in clinical and physiological variables over 6 and 12 months may provide clinicians with more accurate prognostic information than baseline values alone...
  30. ncbi Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
    Brent W Kinder
    Department of Medicine, University of California School of Medicine, San Francisco, California, USA
    Am J Respir Crit Care Med 176:691-7. 2007
    ....
  31. ncbi Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis
    Rafael L Perez
    Pulmonary Division, Department of Medicine, Emory University, Atlanta Veterans Affairs Medical Center, Atlanta, GA 30033, USA
    Respiration 74:297-303. 2007
    ..Abnormalities of lung coagulation and fibrinolysis in sarcoidosis are thought to play a role in the pathogenesis of this disease...
  32. ncbi Acute exacerbations of idiopathic pulmonary fibrosis
    Harold R Collard
    Department of Medicine, San Francisco General Hospital, University of California, USA
    Am J Respir Crit Care Med 176:636-43. 2007
    ..The potential pathobiological roles of infection, disordered cell biology, coagulation, and genetics are discussed, and future research directions are proposed...
  33. ncbi Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus
    M M Freemer
    Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94143-0500, USA
    Ann Rheum Dis 65:581-4. 2006
    ..This information may also serve as a possible point of intervention to prevent disease or target treatment...
  34. ncbi Neurofibromatosis-associated lung disease: a case series and literature review
    A C Zamora
    Department of Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    Eur Respir J 29:210-4. 2007
    ..In conclusion, neurofibromatosis with diffuse lung disease is a definable clinical entity, characterised by upper lobe cystic and bullous disease and lower lobe fibrosis. Its relationship to smoking remains unclear...
  35. ncbi Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis
    Harold R Collard
    Department of Medicine, University of California San Francisco, San Francisco, California, USA
    Am J Physiol Lung Cell Mol Physiol 299:L3-7. 2010
    ..Furthermore, they suggest that acute exacerbation of IPF has a distinct plasma biomarker profile from that of acute lung injury...
  36. ncbi Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus
    Brent W Kinder
    Division of Rheumatology, University of California San Francisco, 374 Parnassus Avenue, San Francisco, CA 94143, USA
    Arthritis Rheum 56:2679-86. 2007
    ....
  37. ncbi Low prevalence of chronic beryllium disease among workers at a nuclear weapons research and development facility
    Mehrdad Arjomandi
    Department of Medicine, University of California, San Francisco, CA, USA
    J Occup Environ Med 52:647-52. 2010
    ..To study the prevalence of beryllium sensitization (BeS) and chronic beryllium disease (CBD) in a cohort of workers from a nuclear weapons research and development facility...
  38. ncbi A critical assessment of treatment options for idiopathic pulmonary fibrosis
    Nirav R Shah
    Department of Medicine, New York University School of Medicine, New York, NY, USA
    Sarcoidosis Vasc Diffuse Lung Dis 22:167-74. 2005
    ....
  39. ncbi Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group
    Ronald G Crystal
    Division of Pulmonary and Critical Care Medicine, Weill Medical College of Cornell University, New York, New York, USA
    Am J Respir Crit Care Med 166:236-46. 2002
    ....
  40. ncbi Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis
    Yoshikazu Inoue
    Division of Environmental and Occupational Health Sciences and Pulmonary Division, Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, USA
    Am J Respir Crit Care Med 166:765-73. 2002
    ..These data suggest that mast cell-derived bFGF might exert fibrogenic, proliferative effects on smooth muscle cell/myofibroblast-like cells through its receptors...
  41. ncbi Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia
    Gary W Hunninghake
    Department of Medicine, University of Iowa and Veterans Administration Medical Center, Iowa City, IA 52242, USA
    Chest 124:1215-23. 2003
    ..To determine which clinical and radiologic findings are independently associated with a pathologic diagnosis of usual interstitial pneumonia (UIP)...
  42. ncbi COPD: a dust-induced disease?
    Carlos E Girod
    Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9034, USA
    Chest 128:3055-64. 2005
    ..Further studies into the effects of kaolinite on macrophage function and the subsequent development of respiratory bronchiolitis could lead to prevention of COPD at its precursor lesion...
  43. ncbi Classification and natural history of the idiopathic interstitial pneumonias
    Dong Soon Kim
    Division of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan, 388 1 Poongnap dong, Songpa Ku, Seoul, Korea, 138 736
    Proc Am Thorac Soc 3:285-92. 2006
    ..However, there is still confusion and controversy over the relationship between idiopathic pulmonary fibrosis and fibrotic nonspecific interstitial pneumonia...
  44. ncbi High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis
    David A Lynch
    Department of Radiology, and Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Box A030, Room 2233 Denver, CO 80262, USA
    Am J Respir Crit Care Med 172:488-93. 2005
    ..High-resolution computed tomography (HRCT) is an integral aspect of the evaluation of patients with suspected idiopathic pulmonary fibrosis (IPF). However, few studies have evaluated its use in a large cohort...
  45. ncbi A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
    Ganesh Raghu
    Division of Pulmonary Medicine, University of Washington, Seattle 98195, USA
    N Engl J Med 350:125-33. 2004
    ..Idiopathic pulmonary fibrosis is a progressive, fatal disease with no known efficacious therapy...
  46. ncbi Respiratory bronchiolitis-interstitial lung disease: long-term outcome
    Joshua Portnoy
    National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206, USA
    Chest 131:664-71. 2007
    ..In this study, we sought to determine the outcome of RB-ILD patients with and without smoking cessation and with and without corticosteroid therapy...
  47. ncbi Nonspecific interstitial pneumonia and systemic sclerosis
    Talmadge E King
    Am J Respir Crit Care Med 165:1578-9. 2002
  48. ncbi The clinical course of patients with idiopathic pulmonary fibrosis
    Fernando J Martinez
    University of Michigan, Ann Arbor, Michigan 48109, USA
    Ann Intern Med 142:963-7. 2005
    ..Prospective data defining the clinical course in idiopathic pulmonary fibrosis (IPF) are sparse...
  49. ncbi Idiopathic interstitial pneumonias: CT features
    David A Lynch
    Department of Radiology, University of Colorado Health Sciences Center, CB A 030, 4200 E Ninth Ave, Denver, CO 80262, USA
    Radiology 236:10-21. 2005
    ..AIP manifests as diffuse lung consolidation and ground-glass opacity. LIP is associated with a CT pattern of ground-glass opacity sometimes associated with perivascular cysts...
  50. ncbi Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project
    William D Travis
    Attending Thoracic Pathologist, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Am J Respir Crit Care Med 177:1338-47. 2008
    ..Concern was expressed that NSIP was a "wastebasket" category, difficult to distinguish from other idiopathic interstitial pneumonias...
  51. ncbi Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate
    Roland Du Bois
    Interstitial Lung Disease Unit, Department of Occupational and Environmental Medicine, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, UK
    Thorax 62:1008-12. 2007
    ..The histopathological pattern of NSIP can be found in a wide variety of clinical and radiological contexts. This review addresses these and other uncertainties regarding NSIP and UIP...
  52. ncbi Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma lung disease
    Brent W Kinder
    Am J Respir Crit Care Med 177:1292-3; author reply 1293. 2008
  53. ncbi The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis
    Jason S Vourlekis
    Lung and Upper Aerodigestive Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Am J Med 116:662-8. 2004
    ..01; 95% confidence interval: 1.68 to 21.45; P = 0.006). CONCLUSION: Pulmonary fibrosis is associated with diminished survival in patients with hypersensitivity pneumonitis...
  54. ncbi Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
    Ana C Zamora
    Hospital Universitario Dr José Eleuterio González, Monterrey, NL, Mexico
    Respir Med 102:150-5. 2008
    ..Treatment of patients with scleroderma ILD for up to 24 months with MMF was generally associated with stable pulmonary function. These data argue for a prospective trial using MMF to treat scleroderma ILD...
  55. ncbi Anticoagulant therapy and idiopathic pulmonary fibrosis
    Brent W Kinder
    Chest 130:302-3. 2006
  56. ncbi Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?
    Kevin R Flaherty
    University of Michigan Health System, Ann Arbor, MI 48109 0360, USA
    Am J Respir Crit Care Med 175:1054-60. 2007
    ..Treatment and prognoses of diffuse parenchymal lung diseases (DPLDs) varies by diagnosis. Obtaining a uniform diagnosis among observers is difficult...
  57. ncbi Racial disparities in clinical trials
    Talmadge E King
    N Engl J Med 346:1400-2. 2002

Research Grants2

  1. Idiopathic Pulmonary Fibrosis Clinical Research Network
    TALMADGE KING; Fiscal Year: 2007
    ..Protocol 2: A randomized, double blind, placebo controlled, multicenter trial of interferon gamma-1b plus pirfenidone in the treatment of IPF. (End of Abstract) ..